Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: One more thing before I leave--

As far as buyout goes, I could be wrong. The ownership of the MMP is setup through phoenix in the event of a take over they wouldn’t get the mmp. 500 hundred million shares is also a good deterrent in case I am not correct on the ownership thing.

Share
New Message
Please login to post a reply